Bank of New York Mellon Corp Sells 64,216 Shares of Agilent Technologies, Inc. $A

Bank of New York Mellon Corp cut its position in Agilent Technologies, Inc. (NYSE:A) by 2.2% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 2,793,604 shares of the medical research company’s stock after selling 64,216 shares during the quarter. Bank of New York Mellon Corp’s holdings in Agilent Technologies were worth $318,415,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Fiduciary Trust Co grew its stake in shares of Agilent Technologies by 1.6% in the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after acquiring an additional 77 shares during the last quarter. NorthCrest Asset Manangement LLC increased its holdings in shares of Agilent Technologies by 1.6% in the fourth quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock valued at $726,000 after purchasing an additional 79 shares in the last quarter. Freestone Capital Holdings LLC grew its holdings in Agilent Technologies by 2.0% during the 4th quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock worth $574,000 after acquiring an additional 84 shares during the period. Grove Bank & Trust increased its position in shares of Agilent Technologies by 5.5% in the 4th quarter. Grove Bank & Trust now owns 1,758 shares of the medical research company’s stock valued at $239,000 after buying an additional 92 shares in the last quarter. Finally, Plan A Wealth LLC lifted its holdings in shares of Agilent Technologies by 3.2% in the fourth quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock valued at $403,000 after purchasing an additional 92 shares in the last quarter.

Agilent Technologies Stock Down 3.5%

Shares of Agilent Technologies stock opened at $131.34 on Friday. The company’s 50 day moving average price is $127.49 and its 200-day moving average price is $125.63. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $160.27. The stock has a market capitalization of $37.09 billion, a price-to-earnings ratio of 26.37, a P/E/G ratio of 2.42 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities research analysts forecast that Agilent Technologies, Inc. will post 6 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be issued a $0.255 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.8%. Agilent Technologies’s dividend payout ratio is 20.48%.

Analysts Set New Price Targets

A has been the topic of several research analyst reports. Barclays upped their price objective on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research note on Wednesday, June 24th. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. TD Cowen boosted their target price on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Piper Sandler assumed coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 target price on the stock. Finally, Bank of America raised Agilent Technologies from a “neutral” rating to a “buy” rating and reduced their target price for the company from $150.00 to $145.00 in a report on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $159.35.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.